Laser Therapy for Treating Hypertrophic Burn Scars in Children
LaserTherapy
Tunable-Dye Laser Therapy to Ameliorate Hypertrophic Scarring in Burned Children
1 other identifier
interventional
80
1 country
1
Brief Summary
Pulse-dye laser therapy has been used to treat the redness, tightness and discomfort of hypertrophic scars resulting from burn injuries. To date the effectiveness of laser therapy on children's burned scars has not been measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 27, 2012
CompletedFirst Posted
Study publicly available on registry
July 31, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedJuly 31, 2012
July 1, 2012
1.8 years
July 27, 2012
July 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Matching Assessment of Scars and Photographs
This scar assessment tool uses a set of reference photographs, a numeric scale, and location technique to measure change over time of a burn scar. This tool will assist us in determining the comparative merits of laser treatments. It is portable and inexpensive.
12 months after the first laser procedure is completed
Secondary Outcomes (1)
Burn Outcomes Questionnaire
Baseline completion after enrollment and again at 1st,2nd, 3rd, 4th,5th and 6th outpatient visits.
Study Arms (2)
Pulse Dye Laser, burn scars
ACTIVE COMPARATORA scar will be located on the study subject's torso or thigh and divided in half. Some subjects will receive laser to both sides of their scar, while others will not receive any intervention to one side and laser to the other side. Each side will be evaluated during outpatient visits. 12 months after treatment is completed, 2 burn experts will rate each side of the scar without knowing its treatment.
No treatment to half of scar
SHAM COMPARATORA scar on the child's torso or thigh will be divided in half. One side will receive laser treatment and the other half will receive laser or sham treatment.
Interventions
Laser therapy will be applied to either one half or both halves of the subject's burn scar. Laser will be re-applied every 4-6 weeks for a total of 3 administrations.
No treatment to one side of subject's scar.
Eligibility Criteria
You may qualify if:
- subjects 9 years and older to 21 years of age or younger with a second degree burn with erythema and the potential for hypertrophic scarring to the thigh and or trunk.
- subject is clinically stable within 3 months of the burn injury.
- burn size of at least 15cm2 and able to be divided into equivalent halves (divided along line of tension). Equivalent orientation distance from mobil joint with regard to history,physical findings, proximity to tension producing forces and orientation.
- subjects can be included up to one year post burn if referred from another treatment facility.
- no skin conditions that could potentially have an adverse effect on wound healing
- all race/ethnic groups
- children/guardians or significant others ability to speak English or Spanish and respond to study questionnaires.
You may not qualify if:
- subjects less than 9 years old as this age group is more fragile.
- subjects with no second degree burn to thigh and or trunk
- subjects with chemical burns
- subjects at low risk for hypertrophic scaring (wounds that demonstrate fading erythema at 9-12 weeks and wounds that are healed at less than 3 weeks are at low risk for hypertrophic scaring). Vancouver scar scale pigmentation rating of 0 or 1, vascularity rating of 0 or 1.
- TBSA greater than 50% as massive burns will confound results.
- potential life threatening injuries which would confound the effects of laser treatment and complicate sequential administration of therapy (e.g. shock,sepsis,inhalation therapies, brain injury).
- children/guardians or significant others inability to speak English or Spanish and respond to questionnaires.
- SUBJECTS WITH DOCUMENTED HYPERSENSITIVITY/ALLERGY TO AQUAPHOR,LIDOCAINE OR ANY OF THEIR COMPONENTS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts General Hospitallead
- Shriners Hospitals for Childrencollaborator
Study Sites (1)
Shriners Hospitals for Children
Cincinnati, Ohio, 45229-3095, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Donelan, MD
Shriners Hospitals for Children-Boston MA USA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 27, 2012
First Posted
July 31, 2012
Study Start
May 1, 2012
Primary Completion
March 1, 2014
Study Completion
January 1, 2015
Last Updated
July 31, 2012
Record last verified: 2012-07